Clinical significance of acute-phase brain natriuretic peptide in acute myocardial infarction treated with direct coronary angioplasty

Journal of Cardiology

Volumn 42, Issue 5, 2003, Pages 195-200

  Katayama, Toshiro ^a   Nakashima, Hiroshi ^a   Yonekura, Tsuyoshi ^a   Honda, Yukiharu ^a   Suzuki, Shin ^a   Yano, Katsusuke ^b  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Heart failure; Interventional cardiology (direct); Myocardial infarction, treatment; Natriuretic peptides, brain; Prognosis; Ventricular remodeling

Indexed keywords

ACUTE PHASE PROTEIN; BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RUPTURE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE REMODELING; HEART VENTRICLE TACHYCARDIA; HEART VENTRICLE WALL MOTION; HEART VENTRICULOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PLASMA; PREDICTION; PROGNOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; VENTRICULAR REMODELING;

EID: 11144231714     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Tsutamoto T, Wada A, Maeda K, Hisanaga T, Maeda Y, Fukai D, Ohnishi M, Sugimoto Y, Kinoshita M: Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96: 509-516
2. Omland T, Aakvaag A, Bonarjee VV, Caidahl K, Lie RT, Nilsen DW, Sundsfjord JA, Dickstein K: Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996; 93: 1963-1969
3. Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, Mukoyama M, Nakao K: Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993; 88: 82-91
4. Inoue T, Sakuma M, Yaguchi I, Mizoguchi K, Uchida T, Takayanagi K, Hayashi T, Morooka S: Early recanalization and plasma brain natriuretic peptide as an indicator of left ventricular function after acute myocardial infarction. Am Heart J 2002; 143: 790-796
5. Nagaya N, Nishikimi T, Goto Y, Miyao Y, Kobayashi Y, Morii I, Daikoku S, Matsumoto T, Miyazaki S, Matsuoka H, Takishita S, Kangawa K, Matsuo H, Nonogi H: Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction. Am Heart J 1998; 135: 21-28
6. Brodie BR, Stuckey TD, Muncy DB, Hansen CJ, Wall TC, Pulsipher M, Gupta N: Importance of time-to-reperfusion in patients with acute myocardial infarction with and without cardiogenic shock treated with primary percutaneous coronary intervention. Am Heart J 2003; 145: 708-715
7. Sakurai K, Watanabe J, Iwabuchi K, Koseki Y, Kon-no Y, Fukuchi M, Komaru T, Shinozaki T, Miura M, Sakuma M, Kagaya Y, Kitaoka S, Shirato K: Comparison of the efficacy of reperfusion therapies for early mortality from acute myocardial infarction in Japan. Circ J 2003; 67: 209-214
8. Sheehan FH, Schofer J, Mathey DG, Kellett MA, Smith H, Bolson EL, Dodge HT: Measurement of regional wall motion from biplane contrast ventriculograms: A comparison of the 30 degree right anterior oblique and 60 degree left anterior oblique projections in patients with acute myocardial infarction. Circulation 1986; 74: 796-804
9. Richards AM, Nicholls MG, Yandle TG, Ikram H, Espiner EA, Turner JG, Buttimore RC, Lainchbury JG, Elliott JM, Frampton C, Crozier IG, Smyth DW, for the Christchurch Cardioendocrine Research Group: Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. Heart 1999; 81: 114-120
10. Darbar D, Davidson NC, Gillespie N, Choy AM, Lang CC, Shyr Y, McNeill GP, Pringle TH, Struthers AD: Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction. Am J Cardiol 1996; 78: 284-287
11. Omland T, Persson A, Ng L, O'Brien R, Karlsson T, Herlitz J, Harford M, Caidahl K: N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 2002; 106: 2913-2918
12. Arakawa N, Nakamura M, Aoki H, Hiramori K: Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol 1996; 27: 1656-1661
13. Uusimaa P, Ruskoaho H, Vuolteenaho O, Niemela M, Lumme J, Ikaheimo M, Jounela A, Peuhkurinen K: Plasma vasoactive peptide after acute myocardial infarction in relation to left ventricular dysfunction. Int J Cardiol 1999; 69: 5-14
14. Mazurek W, Salomon P: The examination of clinical prognostic importance of atrial and brain natriuretic peptide in patients with acute myocardial infarction. Pol Merkuriusz Lek 2002; 67: 15-19
15. Nagaya N, Goto Y, Nishikimi T, Uematsu M, Miyao Y, Kobayashi Y, Miyazaki S, Hamada S, Kuribayashi S, Takamaya M, Matsuo H, Kangawa K, Nonogi H: Sustained elevation of plasma brain natriuretic peptide levels associated with progressive ventricular remodeling after acute myocardial infarction. Clin Sci 1999; 96: 129-136